Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
$1.95
$2.04
$0.95
$8.95
$36.97M0.6738,225 shs1,430 shs
SBM
ProShares Short Basic Materials
$46.38
$46.38
$42.85
$55.15
$1.86MN/A3,024 shsN/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
-4.88%+4.84%+7.14%-1.52%-70.68%
SBM
ProShares Short Basic Materials
0.00%0.00%0.00%0.00%-0.01%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
2.3094 of 5 stars
3.54.00.00.01.11.70.6
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
3.00
Buy$8.00310.26% Upside
SBM
ProShares Short Basic Materials
0.00
N/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
$10K3,697.20N/AN/A$0.20 per share9.75
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
-$13.21M-$1.13N/AN/AN/AN/AN/A-141.23%5/20/2024 (Estimated)
SBM
ProShares Short Basic Materials
N/AN/A0.00N/AN/AN/AN/AN/A

Latest IMM, SBM, OBD, and PMN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
N/A-$0.09-$0.09-$0.09N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
N/AN/AN/AN/AN/A
SBM
ProShares Short Basic Materials
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
N/A
1.46
1.46
SBM
ProShares Short Basic Materials
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
50.13%
SBM
ProShares Short Basic Materials
N/A

Insider Ownership

CompanyInsider Ownership
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
10.30%
SBM
ProShares Short Basic Materials
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ProMIS Neurosciences, Inc. stock logo
PMN
ProMIS Neurosciences
618.96 million17.01 millionNot Optionable
SBM
ProShares Short Basic Materials
N/A40,000N/ANot Optionable

IMM, SBM, OBD, and PMN Headlines

SourceHeadline
FTSEAthex Basic Materials (FTATBM)FTSEAthex Basic Materials (FTATBM)
investing.com - April 17 at 1:11 PM
Fundamentals of Materials for Energy and Environmental SustainabilityFundamentals of Materials for Energy and Environmental Sustainability
cambridge.org - March 24 at 5:46 PM
Sh4b set aside for CBC classrooms missingSh4b set aside for CBC classrooms missing
standardmedia.co.ke - February 25 at 10:22 PM
TTT ProShares UltraPro Short 20+ Year Treasury ETFTTT ProShares UltraPro Short 20+ Year Treasury ETF
seekingalpha.com - December 24 at 6:36 PM
ProShares Short Basic Materials (SBM)ProShares Short Basic Materials (SBM)
finance.yahoo.com - November 23 at 7:46 AM
All IndicesAll Indices
thestreet.com - September 18 at 9:22 PM
ProShares Short Financials (SEF)ProShares Short Financials (SEF)
investing.com - August 24 at 3:19 PM
ProShares Short Basic Materials NewsProShares Short Basic Materials News
thestreet.com - August 23 at 11:58 PM
Volatile Market Conditions Could Drive Investors to TradeVolatile Market Conditions Could Drive Investors to Trade
investopedia.com - July 23 at 10:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ProMIS Neurosciences logo

ProMIS Neurosciences

NASDAQ:PMN
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

ProShares Short Basic Materials

NYSEARCA:SBM
ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.